Evidence map›Paper›PMID 42154343›Full record

ArticleWorld journal of microbiology & biotechnology2026

Integrative 16S rRNA characterization, pan-genome, and immunoinformatics approaches for the design of a multi-epitope vaccine against Bacillus cereus, a foodborne pathogen.

Muhammad Asim, Muhammad Naveed, Tariq Aziz, Muhammad Toheed, Hafiz Muzzammel Rehman, Nawal Al-Hoshani, Rania Ali El Hadi Mohamed, Maher S Alwethaynani, Areej A Alhhazmi, Manal F Elkhadragy

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Muhammad AsimDepartment of Biotechnology, Faculty of Science and Technology, University of Central Punjab, Lahore, 54000, Pakistan.
Muhammad NaveedDepartment of Biotechnology, Faculty of Science and Technology, University of Central Punjab, Lahore, 54000, Pakistan. naveed.quaidian@gmail.com.
Tariq AzizLaboratory of Animal Health, Hygiene and Food Quality, University of Ioannina Arta Greece, Arta, Greece. iwockd@gmail.com.
Muhammad ToheedDepartment of Biotechnology, Faculty of Science and Technology, University of Central Punjab, Lahore, 54000, Pakistan.
Hafiz Muzzammel RehmanSchool of Biochemistry & Biotechnology, University of the Punjab, Lahore, Pakistan.
Nawal Al-HoshaniDepartment of Biology, College of Sciences, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh, 11671, Saudi Arabia.
Rania Ali El Hadi MohamedDepartment of Biology, College of Sciences, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh, 11671, Saudi Arabia.
Maher S AlwethaynaniDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, Shaqra University, Alquwayiyah, Riyadh, Saudi Arabia.
Areej A AlhhazmiClinical Laboratory Sciences Department. Applied Medical Sciences, Taibah University, Medina, Saudi Arabia.
Manal F ElkhadragyDepartment of Biology, College of Sciences, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh, 11671, Saudi Arabia.

Funding

Princess Nourah Bint Abdulrahman University PNURSP2026R437
6 · The paper itself

Abstract

Bacillus cereus is a spore-forming foodborne pathogen responsible for diarrheal and emetic syndromes, as well as severe opportunistic infections. Its persistence in diverse environments and intrinsic resistance mechanisms highlight the urgent need for effective preventive strategies, particularly in the absence of licensed vaccines. In this study, an integrated computational and immunoinformatics approach was employed to identify conserved antigenic targets and design a multi-epitope vaccine candidate against Bacillus cereus. Pan-genome analysis enabled the identification of conserved antigenic proteins, followed by epitope prediction and construction of a multi-epitope vaccine. The designed construct exhibited strong antigenicity, stability, and solubility, with 97.3% of residues located in the favored regions of the Ramachandran plot and a ProSA-web Z-score within the range of native proteins. Molecular docking analysis demonstrated a favorable binding affinity for Toll-like receptor 2 (TLR2), while molecular dynamics simulations confirmed the structural stability of the complex. Codon optimization enhanced expression potential by reducing the GC content from 70.10% to 56.80%. Immune simulations predicted robust IgG responses, Th1-skewed cytokine production, and the development of immunological memory. Overall, the designed multi-epitope vaccine demonstrates strong in silico immunogenic potential, broad global population coverage (96.98%), and favorable expression feasibility. These findings support the proposed construct as a promising vaccine candidate; however, experimental validation through in vitro and in vivo studies is required to confirm its efficacy.

Indexed as

Bacillus cereusBacterial VaccinesEpitopesAntigens, BacterialComputational BiologyGenome, BacterialImmunoglobulin GImmunoinformaticsMolecular Docking SimulationMolecular Dynamics SimulationProtein Subunit VaccinesToll-Like Receptor 2Antigens, BacterialBacterial VaccinesEpitopesImmunoglobulin GProtein Subunit VaccinesToll-Like Receptor 216S rRNA geneBacillus cereusmolecular dynamics simulationsmulti-epitope vaccinepan-genome analysisToll-like receptors

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.